Retinal Pigment Epithelium (RPE) Differentiation | ASC

Human iPSC-derived retinal pigment epithelium (RPE) provides a physiologically relevant cell line model to understand basic ocular biology and ocular diseases. ASC’s optimized RPE differentiation protocol allows for the generation of high-quality RPE cells that express lineage-committed markers. In just a few weeks (16-20 weeks) you can produce the RPE cells you need to push your research to the next stage.

• • RPE-like cells with typical cobblestone morphology and pigmentation

• • High-quality and purity cells expressing RPE-specific markers

• • RPE differentiated from iPSCs:
    • • Your healthy/ disease/engineered iPSCs

     

    • • 
        iPSC generation
        
        from fibroblast/PBMC/ CD34+ cord blood cells

     

    • • Optional!
        
        Control lines
        

     

     

• • 
    Fast turnaround time: 2 months
    

• • 
    GMP iPSC Differentiation Services Available >> Learn More
    

Looking for iPSCs to genetically modify and further differentiate into RPE? We offer fully customizable

iPSC generation

from human or non-human tissue samples, and our genome editing experts can use

CRISPR or TARGATT™  to genetically alter the iPSCs

to suit your projects. If you need to expedite your experimental timeline, ASC also offers off-the-shelf

iPSC-derived RPE and Photoreceptor cells

. Contact us today to find the best solution for your research.